Wellington Management Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44,922	Closed	-$8.25M	–	2353
2021 Q2	$8.25M	Sell	44,922 -4,437	-9%	-$762K	﹤0.01%	1343
2021 Q1	$7.55M	Sell	49,359 -136,162	-73%	-$21.1M	﹤0.01%	1313
2020 Q4	$29M	Buy	185,521 +159,442	+611%	+$20.5M	0.01%	949
2020 Q3	$2.98M	Buy	26,079 +13,135	+101%	+$1.42M	﹤0.01%	1356
2020 Q2	$1.45M	Sell	12,944 -1,133	-8%	-$120K	﹤0.01%	1412
2020 Q1	$1.26M	Sell	14,077 -5,470	-28%	-$537K	﹤0.01%	1466
2019 Q4	$2.11M	Buy	19,547 +2,496	+15%	+$267K	﹤0.01%	1537
2019 Q3	$1.67M	Sell	17,051 -2,865	-14%	-$323K	﹤0.01%	1629
2019 Q2	$2.61M	Buy	19,916 +7,252	+57%	+$935K	﹤0.01%	1549
2019 Q1	$1.71M	Sell	12,664 -584	-4%	-$72.6K	﹤0.01%	1656
2018 Q4	$1.29M	Buy	13,248 +130	+1%	+$15.4K	﹤0.01%	1747
2018 Q3	$1.82M	Sell	13,118 -8,414	-39%	-$1.06M	﹤0.01%	1727
2018 Q2	$2.67M	Buy	21,532 +6,881	+47%	+$804K	﹤0.01%	1656
2018 Q1	$1.63M	Buy	+14,651	New	+$1.75M	﹤0.01%	1789
2017 Q4	–	Sell	-2,314	Closed	-$325K	–	2340
2017 Q3	$325K	Buy	+2,314	New	+$314K	﹤0.01%	2117
2015 Q3	–	Sell	-1,115	Closed	-$202K	–	2278
2015 Q2	$202K	Sell	1,115 -45,668	-98%	-$7.88M	﹤0.01%	2104
2015 Q1	$8.11M	Sell	46,783 -112,304	-71%	-$20.3M	﹤0.01%	1303
2014 Q4	$29.4M	Buy	159,087 +109,163	+219%	+$20.2M	0.01%	916
2014 Q3	$8.28M	Buy	49,924 +1,827	+4%	+$300K	﹤0.01%	1297
2014 Q2	$7.51M	Buy	48,097 +1,892	+4%	+$299K	﹤0.01%	1333
2014 Q1	$7.03M	Buy	+46,205	New	+$7.35M	﹤0.01%	1343
2013 Q4	–	Sell	-30,635	Closed	-$3.56M	–	2250
2013 Q3	$3.56M	Buy	+30,635	New	+$3.36M	﹤0.01%	1513

Other funds holding ALXN